Matthew Buten

Matthew Buten

Director Financiero/CFO en BIOHAVEN LTD. .

Fortuna: 2 M $ al 31/05/2026

64 años
Finance
Technology Services
Health Technology

Perfil

Matthew Buten was the founder of Argus Partners LLC, Sapphire Capital Partners LLP.
Mr. Buten is currently Chief Financial Officer at Biohaven Ltd. since 2022.
Formerly, Mr. Buten was Chief Financial Officer & Director at Biohaven Pharmaceutical Holding Co. Ltd. from 2021 to 2022, Managing Director at Foresite Capital Management LLC from 2012 to 2021, Manager-Healthcare Portfolio at Millennium Management LLC and Catapult Capital Management LLC from 2007 to 2012, Research Analyst at Sivik Global Healthcare LLC (Old) from 2003 to 2005, MD & Head-Healthcare Investment Banking at Needham & Co. LLC from 1996 to 2000, Director-Investment Banking at Smith Barney, Inc. from 1985 to 1996, Analyst at Galleon Management LP.
in 2001, and Director at Sotera Wireless, Inc. Mr. Buten completed undergraduate studies at The Wharton School of the University of Pennsylvania in 1983.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
03/03/2026 195.652 ( 0,13 % ) 2 M $ 31/05/2026

Cargos activos de Matthew Buten

EmpresasCargoInicio
BIOHAVEN LTD. Director Financiero/CFO 28/09/2022

Antiguos cargos conocidos de Matthew Buten.

EmpresasCargoFin
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. Director Financiero/CFO 03/10/2022
Inversor de Capital Privado 01/12/2021
Director/Miembro de la Junta 01/08/2016
Corporate Officer/Principal 01/06/2012
Gestor de Cartera-Acciones 01/06/2012
Ver el detalle de la experiencia de Matthew Buten.

Formación de Matthew Buten.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

95

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Finance

Finance

Technology Services

Finance

Finance

Finance

Finance

Technology Services

Finance

Consumer Services

Health Technology

Finance

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN